Mutations in IDH1 and IDH2 are another important class of genetic alterations in AML, resulting in the production of the oncometabolite R-2-hydroxyglutarate (R-2HG), which disrupts normal DNA methylation and contributes to leukemogenesis [9,10]. The gene discussed is IDH2; the disease is acute myeloid leukemia.